BRIEF published on 07/07/2025 at 15:05, 8 days 23 hours ago Applied DNA Sciences se conforme aux normes de cotation du Nasdaq Biotechnologie Sciences Appliquées De L'ADN Conformité Au Nasdaq Technologies De L'ADN LineaRx
BRIEF published on 07/07/2025 at 15:05, 8 days 23 hours ago Applied DNA Sciences Complies with Nasdaq Listing Standards Biotechnology Nasdaq Compliance Applied DNA Sciences DNA Technologies LineaRx
PRESS RELEASE published on 07/07/2025 at 15:00, 8 days 23 hours ago Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements Applied DNA Sciences regains compliance with Nasdaq listing rule requiring minimum bid price of $1.00 per share. Company's securities to remain listed on Nasdaq Capital Market Nasdaq Compliance Applied DNA Sciences Nasdaq Capital Market Minimum Bid Price PCR-based DNA Technologies
BRIEF published on 06/17/2025 at 22:15, 28 days 15 hours ago Transition de direction chez Applied DNA : le Dr Hayward, PDG, prend sa retraite Biotechnologie Changement De Direction Valeur Actionnariale ADN Appliqué Judy Murrah
BRIEF published on 06/17/2025 at 22:15, 28 days 15 hours ago Leadership Transition at Applied DNA as CEO Dr. Hayward Retires Biotechnology Shareholder Value Leadership Change Applied DNA Judy Murrah
PRESS RELEASE published on 06/17/2025 at 22:10, 28 days 16 hours ago Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward Judy Murrah appointed Chairperson and CEO of Applied DNA Sciences, succeeding Dr. James A. Hayward. Experienced executive aims to lead company's innovative DNA technologies CEO Appointment Applied DNA Sciences DNA Technologies Judy Murrah Dr. James A. Hayward
BRIEF published on 05/15/2025 at 22:10, 2 months ago Applied DNA Sciences enregistre une croissance modeste de ses revenus au deuxième trimestre 2025 Croissance Des Revenus Restructuration Stratégique Résultats Financiers Du Deuxième Trimestre Tendances Biopharmaceutiques Technologie De L'ADN
BRIEF published on 05/15/2025 at 22:10, 2 months ago Applied DNA Sciences Sees Modest Revenue Growth in Q2 2025 Revenue Growth Strategic Restructuring Q2 Financial Results DNA Technology Biopharma Trends
PRESS RELEASE published on 05/15/2025 at 22:05, 2 months ago Applied DNA Reports Second Quarter Fiscal 2025 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) reports a 44% Y/Y increase in LineaRx segment revenues contributing to a 6% total revenue growth. Strategic priorities and financial highlights for Q2 2025 disclosed Financial Results Strategic Priorities Applied DNA Sciences LineaRx Segment Therapeutic DNA Production
BRIEF published on 05/14/2025 at 17:35, 2 months 1 day ago Applied DNA Sciences publiera ses résultats financiers du deuxième trimestre et organisera une mise à jour pour les investisseurs Sciences Appliquées De L'ADN Conférence Téléphonique Pour Les Investisseurs Priorités Stratégiques Rediffusion Du Webcast Résultats Financiers Du Deuxième Trimestre 2025
Published on 07/16/2025 at 14:00, 10 minutes ago AgriFORCE Launches Alberta Compute Site, Strengthens Strategic Asset Accumulation Framework
Published on 07/16/2025 at 13:45, 25 minutes ago Amarc and Freeport Launch 2025 Aurora and Joy Copper-Gold District Drilling, Consolidate Additional District Potential
Published on 07/16/2025 at 13:30, 40 minutes ago Sterling Metals Announces Upsize of Private Placement Of Units and Flow-Through Shares
Published on 07/16/2025 at 13:30, 40 minutes ago Nextech3D.ai Announces Rollout of Crypto Payments with USDC -USD Coin and USDT -Tether
Published on 07/16/2025 at 13:00, 1 hour 10 minutes ago Aclara Teams up with Stanford's Mineral-X to Pioneer AI-Driven Rare Earths Research
Published on 07/16/2025 at 11:41, 2 hours 28 minutes ago La part des véhicules électriques augmente, mais l'incertitude économique affaiblit le marché
Published on 07/16/2025 at 10:29, 3 hours 40 minutes ago Edison issues report on Baker Steel Resources Trust (BSRT)
Published on 07/16/2025 at 07:00, 7 hours 10 minutes ago Biophytis Wins Major Legal Victory Before the French Court of Cassation
Published on 07/16/2025 at 07:00, 7 hours 10 minutes ago Biophytis remporte une victoire majeure devant la Cour de cassation
Published on 07/15/2025 at 19:24, 18 hours 45 minutes ago Reporting on share buyback transactions carried out between July 7 and July 8, 2025
Published on 07/15/2025 at 19:24, 18 hours 45 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 7 et 8 juillet 2025
Published on 07/15/2025 at 18:00, 20 hours 10 minutes ago Déclaration des transactions sur actions propres réalisées du 7 au 11 juillet 2025 dans le cadre du programme de rachat d’actions
